Libya vs Moldova: Access to anti-retroviral drugs, male (%)
Libya
49.0%
in 2023
Moldova
47.0%
in 2024
Libya rank
119th
Moldova rank
122nd
Access to anti-retroviral drugs, male (%) over time
- Libya
- Moldova
How they compare
Libya currently reports 49.0% against 47.0% in Moldova, a difference of 2.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Libya ranks 119th and Moldova ranks 122nd of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.0% | 1.4% | 27.6% | Libya |
| 2010s | 63.9% | 16.0% | 47.9% | Libya |
| 2020s | 47.8% | 37.2% | 10.5% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Libya or Moldova?
- Libya, at 49.0% against 47.0% in Moldova as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Libya and Moldova?
- 2.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Moldova?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and Moldova rank globally for access to anti-retroviral drugs, male?
- Libya ranks 119th and Moldova ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.